EUVIMEDEUVIMED entdecken
Open Access

Impact of myocardial perfusion and coronary calcium on medical management for coronary artery disease

Waseem Hijazi, Yuanchao Feng, Danielle A Southern, Derek Chew iD, Neil Filipchuk, Bryan Har, Matthew James, Stephen Wilton, Piotr J Slomka, Daniel Berman, Robert J H Miller iD

European Heart Journal - Cardiovascular Imaging · 2024

DOI: 10.1093/ehjci/jead288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2024. Verfasst von Waseem Hijazi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Sciences, University of Calgary, 1403 - 29th St. NW, Calgary, AB, T2N 2T9, Canada. Hauptthemen laut MEDLINE: Coronary Artery Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myocardial Perfusion Imaging. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) remains one of the most widely used imaging modalities for the diagnosis and prognostication of coronary artery disease (CAD). Despite the extensive prognostic information provided by MPI, little is known about how this influences the prescription of medical therapy for CAD. We evaluated the relationship between MPI with computed tomography (CT) attenuation correction and prescription of acetylsalicylic acid (ASA) and statins. Methods and results We performed a retrospective analysis of consecutive patients who underwent SPECT MPI at a single centre between 2015 and 2021. Myocardial perfusion abnormalities and coronary calcium burden were assessed, with attenuation correction imaging 77.8% of patients. Medication prescriptions before and within 180 days after the test were compared. Associations between abnormal perfusion and calcium burden with ASA and statin prescription were assessed using multivariable logistic regression. In total, 9908 patients were included, with a mean age 66.8 ± 11.7 years and 5337 (53.9%) males. The prescription of statins increased more in patients with abnormal perfusion (increase of 19.2 vs. 12.0%, P < 0.001). Similarly, the presence of extensive CAC led to a greater increase in statin prescription compared with no calcium (increase 12.1 vs. 7.8%, P < 0.001). In multivariable analyses, ischaemia and coronary artery calcium were independently associated with ASA and statin prescription.

Conclusion

Abnormal MPI testing was associated with significant changes in medical therapy. Both calcium burden and perfusion abnormalities were associated with increased prescriptions of medical therapy for CAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsMyocardial Perfusion ImagingMaleHumansMiddle AgedAgedFemaleCalciumRetrospective StudiesTomography, Emission-Computed, Single-PhotonPerfusionCoronary Angiography

Stichwörter der Autor:innen

coronary artery diseasemedical therapymyocardial perfusion imaging

Substanzen

CalciumHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Cardiac Sciences, University of Calgary, 1403 - 29th St. NW, Calgary, AB, T2N 2T9, Canada.
  • Department of Medicine, Cumming School of Medicine, University of Calgary, 1403 - 29th St. NW, Calgary, AB, T2N 2T9, Canada.
  • Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 1403 - 29th St. NW, Calgary, AB, T2N 2T9, Canada.
  • O'Brien Institute for Public Health, University of Calgary, 1403 - 29th St. NW, Calgary, AB, T2N 2T9, Canada.
  • Libin Cardiovascular Institute, University of Calgary, 1403 - 29th St. NW, Calgary, AB, T2N 2T9, Canada.
  • Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

ORCID-Profile: Derek Chew, Robert J H Miller

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health

Zitieren

APA

Hijazi, W., Feng, Y., Southern, D. A., Chew, D., Filipchuk, N., Har, B., James, M., Wilton, S., Slomka, P. J., Berman, D., & Miller, R. J. H. (2024). Impact of myocardial perfusion and coronary calcium on medical management for coronary artery disease. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jead288

Vancouver

Hijazi W, Feng Y, Southern DA, Chew D, Filipchuk N, Har B, et al. Impact of myocardial perfusion and coronary calcium on medical management for coronary artery disease. European Heart Journal - Cardiovascular Imaging. 2024. doi:10.1093/ehjci/jead288

BibTeX
@article{Hijazi2024,
  author = {Hijazi, Waseem and Feng, Yuanchao and Southern, Danielle A and Chew, Derek and Filipchuk, Neil and Har, Bryan and James, Matthew and Wilton, Stephen and Slomka, Piotr J and Berman, Daniel and Miller, Robert J H},
  title = {Impact of myocardial perfusion and coronary calcium on medical management for coronary artery disease},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2024},
  doi = {10.1093/ehjci/jead288}
}
Kostenlos starten →